Scarica l'app Stockscreener
72.87
1.96%
-1.46
Dopo l'orario di chiusura:
72.00
-0.87
-1.19%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CORT Giù?
Forum
Previsione
Corcept Therapeutics Inc Borsa (CORT) Ultime notizie
Canaccord Genuity Group Issues Positive Forecast for Corcept Therapeutics (NASDAQ:CORT) Stock Price - MarketBeat
United Services Automobile Association Takes $693,000 Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Scientech Research LLC Has $1.62 Million Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
AQR Capital Management LLC Sells 23,561 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Analysts Set Corcept Therapeutics Incorporated (NASDAQ:CORT) Price Target at $134.50 - MarketBeat
FDA Accepts Corcept's NDA for Relacorilant in Ovarian Cancer - sharewise.com
Bayforest Capital Ltd Acquires 5,739 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Empowered Funds LLC Has $13.97 Million Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept’s (CORT) Multibagger Momentum Builds on Relacorilant and Expanding Commercial Footprint - Insider Monkey
FDA Accepts NDA for Relacorilant in Platinum-Resistant Ovarian Cancer - Targeted Oncology
Central serous chorioretinopathy Pipeline Analysis & Clinical - openPR.com
Central serous chorioretinopathy Pipeline Analysis & Clinical Trials, 2025, DelveInsight | Targeted Therapy Technologies, Corcept Therapeutics, Bayer, and others - Barchart.com
Jacobs Levy Equity Management Inc. Decreases Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Coppell Advisory Solutions LLC Purchases 14,590 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept's ovarian cancer treatment under FDA review (CORT) - Seeking Alpha
Corcept Therapeutics Says FDA Accepts NDA on Relacorilant for Treating Ovarian Cancer - MarketScreener
Fda reviews Corcept's nda for relacorilant in drug-resistant ovarian cancer - MarketScreener
FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer - Business Wire
Checkpoint Capital L.P. Acquires Shares of 5,000 Corcept Therapeutics Incorporated $CORT - MarketBeat
Published on: 2025-09-08 19:18:57 - beatles.ru
Predicting Corcept Therapeutics Incorporated trend using moving averages2025 Price Momentum & Fast Exit Strategy with Risk Control - Newser
Canaccord Genuity Maintains a Buy on Corcept Therapeutics (CORT), Retains a $137 PT - MSN
Is Corcept Therapeutics Incorporated a good ESG investmentJuly 2025 Action & Entry Point Confirmation Alerts - خودرو بانک
Published on: 2025-09-06 00:29:23 - خودرو بانک
Ieq Capital LLC Buys 7,844 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Can Corcept Therapeutics Incorporated weather a recession2025 Trade Ideas & Free Safe Capital Growth Stock Tips - خودرو بانک
Corcept Therapeutics Incorporated stock retracement – recovery analysisQuarterly Profit Report & AI Forecasted Entry and Exit Points - Newser
predicting corcept therapeutics incorporated trend using moving averagesJuly 2025 Weekly Recap & Real-Time Chart Pattern Alerts - Newser
Can Corcept Therapeutics Incorporated hit a new high this monthJuly 2025 Short Interest & Safe Capital Allocation Plans - Newser
Is it time to cut losses on Corcept Therapeutics IncorporatedInsider Buying & Safe Capital Allocation Plans - Newser
Key resistance and support levels for Corcept Therapeutics IncorporatedDollar Strength & Reliable Intraday Trade Alerts - Newser
Assessing Insider Selling at Corcept Therapeutics: Strategic and Market Implications - AInvest
Corcept therapeutics CEO Belanoff sells $2.8m in shares By Investing.com - Investing.com Canada
Raymond James Financial Inc. Has $8.90 Million Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics officer Maduck sells $1.4m in shares By Investing.com - Investing.com South Africa
Corcept Therapeutics officer Maduck sells $1.4m in shares - Investing.com India
Corcept therapeutics exec Guyer sells $1.4m in shares By Investing.com - Investing.com Canada
Lyon of Corcept Therapeutics sells $351k in shares By Investing.com - Investing.com Canada
Corcept therapeutics exec Guyer sells $1.4m in shares - Investing.com India
Corcept therapeutics CEO Belanoff sells $2.8m in shares - Investing.com
Corcept Therapeutics Incorporated stock momentum explainedMarket Growth Summary & High Accuracy Trade Signal Alerts - Newser
Price momentum metrics for Corcept Therapeutics Incorporated explainedQuarterly Earnings Summary & Reliable Price Breakout Signals - Newser
259,650 Shares in Corcept Therapeutics Incorporated $CORT Purchased by Driehaus Capital Management LLC - MarketBeat
How to track smart money flows in Corcept Therapeutics IncorporatedJuly 2025 Opening Moves & High Conviction Buy Zone Alerts - Newser
Pattern recognition hints at Corcept Therapeutics Incorporated upside2025 Volume Leaders & AI Driven Stock Movement Reports - Newser
Can momentum traders help lift Corcept Therapeutics IncorporatedPortfolio Update Report & Safe Capital Investment Plans - Newser
Published on: 2025-09-03 06:08:46 - Newser
Applying sector rotation models to Corcept Therapeutics Incorporated2025 Market WrapUp & High Accuracy Trade Signal Alerts - Newser
Will Corcept Therapeutics Incorporated benefit from geopolitical trendsQuarterly Market Summary & Long-Term Growth Plans - خودرو بانک
Published on: 2025-09-03 11:50:42 - خودرو بانک
Quantitative breakdown of Corcept Therapeutics Incorporated recent moveDay Trade & Stepwise Swing Trade Plans - Newser
What are the future prospects of Corcept Therapeutics IncorporatedJuly 2025 Summary & Safe Capital Growth Trade Ideas - خودرو بانک
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):